Febuxostat and atrial fibrillation

Eur Heart J. 2020 Aug 7;41(30):2916-2917. doi: 10.1093/eurheartj/ehaa179.

Authors

Masanari Kuwabara¹, Claudio Borghi², Richard J Johnson³

Affiliations

¹ Intensive Care Unit and Department of Cardiology, Toranomon Hospital, 2-2-2-Toranomon, Minato-ku, Tokyo 105-8470, Japan.
² Department of Medical and Surgical Sciences, University of Bologna, Italy.
³ Division of Renal Diseases and Hypertension, School of Medicine, University of Colorado Denver, CO, USA.

PMID: 32227166
DOI: 10.1093/eurheartj/ehaa179

No abstract available

Publication types

Comment

MeSH terms

Aged
Allopurinol / therapeutic use
Atrial Fibrillation* / drug therapy
Febuxostat / therapeutic use
Gout Suppressants / adverse effects
Gout* / drug therapy
Humans
Medicare
United States

Substances

Gout Suppressants
Febuxostat
Allopurinol